Venture Certified
| 벤처투자유형 | 2020-12-03 ~ 2022-12-02 | 20200301393 | 2020-12-03 |
| 벤처투자유형 | 2022-12-03 ~ 2025-12-02 | 20221110010045 | 2020-12-03 |
| 벤처투자유형 | 2025-12-03 ~ 2028-12-02 | 20251105010037 | 2020-12-03 |
Revenue CAGR +16.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.1B |
| Operating Profit | -23B | -29B | -22B |
| Net Profit | -24B | -29B | -23B |
| Total Assets | 5.7B | 17B | 5.4B |
| Total Liabilities | 23B | 15B | 12B |
| Total Equity | -17B | 1.4B | -6.6B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -23B
3 Consecutive Years of Net Loss
▲ 15.3%
▲ 10.7%
▲ 22.7%
▼ 129.7%
▲ 116.1%
| Name | Position | Role |
|---|---|---|
| 배현수 | 대표이사 | 대표 |
| Regular Employees | 9persons |
| CEO | 배현수 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울 동대문구",
"ceo_name": "배현수",
"certificate": [
{
"cert_number": "20200301393",
"changes": "",
"disclosure_date": "2020-12-03",
"first_cert_date": "2020-12-03",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2020-12-03 ~ 2022-12-02"
},
{
"cert_number": "20221110010045",
"changes": "",
"disclosure_date": "2022-11-10",
"first_cert_date": "2020-12-03",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-12-03 ~ 2025-12-02"
},
{
"cert_number": "20251105010037",
"changes": "",
"disclosure_date": "2025-11-05",
"first_cert_date": "2020-12-03",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-12-03 ~ 2028-12-02"
}
],
"company_name": "트윈피그바이오랩(주)",
"financials": {
"2022": {
"capital_stock": 268122000,
"cost_of_sales": 0,
"current_assets": 244150000,
"current_liabilities": 734605000,
"gross_profit": 112273000,
"net_income": -2260054000,
"net_income_bs": -2260054000,
"non_current_assets": 298305000,
"non_current_liabilities": 472211000,
"non_operating_expenses": 19882000,
"non_operating_income": 4109000,
"operating_profit": -2244281000,
"revenue": 112273000,
"sga_expenses": 2356554000,
"total_assets": 542455000,
"total_equity": -664361000,
"total_liabilities": 1206816000
},
"2023": {
"capital_stock": 661100000,
"cost_of_sales": 0,
"current_assets": 1460222000,
"current_liabilities": 1383256000,
"gross_profit": 152589000,
"net_income": -2931227000,
"net_income_bs": -2931227000,
"non_current_assets": 209730000,
"non_current_liabilities": 145507000,
"non_operating_expenses": 67341000,
"non_operating_income": 59760000,
"operating_profit": -2923646000,
"revenue": 152589000,
"sga_expenses": 3076235000,
"total_assets": 1669952000,
"total_equity": 141189000,
"total_liabilities": 1528763000
},
"2024": {
"capital_stock": 678001000,
"cost_of_sales": 0,
"current_assets": 402927000,
"current_liabilities": 1627148000,
"gross_profit": 152658000,
"net_income": -2364132000,
"net_income_bs": -2364132000,
"non_current_assets": 168744000,
"non_current_liabilities": 635554000,
"non_operating_expenses": 60915000,
"non_operating_income": 5338000,
"operating_profit": -2308555000,
"revenue": 152658000,
"sga_expenses": 2461213000,
"total_assets": 571671000,
"total_equity": -1691031000,
"total_liabilities": 2262702000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "178,500,000",
"changes": "178,500,000",
"date": "2023-12-27"
},
{
"amount": "121,500,000",
"changes": "121,500,000",
"date": "2023-12-27"
},
{
"amount": "127,000,000",
"changes": "127,000,000",
"date": "2022-09-14"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2021-09-03"
},
{
"amount": "140,000,000",
"changes": "140,000,000",
"date": "2021-03-25"
},
{
"amount": "50,046,000",
"changes": "50,046,000",
"date": "2020-10-30"
}
],
"phone": "02-964-****",
"source": "pg_migration"
}{
"address": "서울 동대문구 회기로 117-3 서울바이오허브 글로벌센터 501호(회기동)",
"employee_count": 9,
"establishment_date": "20200501",
"source": "pg_migration",
"workplace_name": "트윈피그바이오랩(주)"
}Data Quality: 80/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |